DelveInsight’s “Exophthalmos- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Exophthalmos, historical and forecasted epidemiology as well as the Exophthalmos market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Exophthalmos Overview
Exophthalmos (also known as proptosis) is the protrusion of one eye or both anteriorly out of the orbit. It derives from Greek, meaning ‘bulging eyes. It occurs due to an increase in orbital contents in the regular anatomy of the bony orbit. Depending on the underlying cause, exophthalmos may be accompanied by systemic symptoms. Vision may be disturbed if the optic nerve is compressed in conjunction with the underlying etiology of exophthalmos.
Exophthalmos Epidemiology Insights
Bartley et al had reported a frequency of 2.9 cases per 100,000 population per year in men and 16 cases per 100,000 population per year in women. They also observed a bimodal distribution in both sexes, with women showing one peak at age 40-44 years and the other peak at age 60-64 years.
The exact prevalence (i.e. the number of people who have a disorder in a specific population at a specific time) of thyroid eye disease is not known but is estimated to be 16 per 100,000 women in the general population, and 2.9 per 100,000 men in the general population
Click here to learn more about the Exophthalmos Market Landscape
The Report Covers the Exophthalmos Epidemiology Segmented by:
Total Exophthalmos incident cases
Total Exophthalmos prevalent cases
Total Exophthalmos treatment cases
Total Exophthalmos diagnostic cases
Exophthalmos Market Outlook
The Exophthalmos market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Exophthalmos market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a thorough detail of Exophthalmos market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.According to DelveInsight, the Exophthalmos market in 7MM is expected to change in the study period 2019-2032.
Key Companies Working in the Exophthalmos Market
Horizon Pharma
Sling Therapeutics
Novartis Pharmaceuticals
Immunovant Sciences Gmbh
And many others
Exophthalmos Therapies Covered and Analyzed in the Report:-
LIPO-102
Teprotumumab
Linsitinib
Tepezza
Learn more about the Key Companies and Emerging Therapies in the Exophthalmos Market.
Table of Contents
Key Insights
Exophthalmos Introduction
Executive Summary of Exophthalmos
Disease Background and Overview
Epidemiology and patient population
Exophthalmos Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Exophthalmos Market Outlook.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services